1566 related articles for article (PubMed ID: 20217518)
1. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
3. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
4. Toward cell-based therapy of type I diabetes.
Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
[TBL] [Abstract][Full Text] [Related]
5. Cell therapy for type 1 diabetes.
Loretelli C; Assi E; Seelam AJ; Ben Nasr M; Fiorina P
Expert Opin Biol Ther; 2020 Aug; 20(8):887-897. PubMed ID: 32299257
[TBL] [Abstract][Full Text] [Related]
6. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Domouky AM; Hegab AS; Al-Shahat A; Raafat N
Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
[TBL] [Abstract][Full Text] [Related]
8. Thymus and type 1 diabetes: an update.
Geenen V
Diabetes Res Clin Pract; 2012 Oct; 98(1):26-32. PubMed ID: 22717497
[TBL] [Abstract][Full Text] [Related]
9. Prevention of beta-cell destruction in autoimmune diabetes: current approaches and future prospects.
Sedimbi SK; Sanjeevi CB
Adv Exp Med Biol; 2010; 654():611-26. PubMed ID: 20217516
[TBL] [Abstract][Full Text] [Related]
10. Chemokines as Drivers of the Autoimmune Destruction in Type 1 Diabetes: Opportunity for Therapeutic Intervention in Consideration of an Optimal Treatment Schedule.
Christen U; Kimmel R
Front Endocrinol (Lausanne); 2020; 11():591083. PubMed ID: 33193102
[TBL] [Abstract][Full Text] [Related]
11. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
Brezar V; Carel JC; Boitard C; Mallone R
Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
[TBL] [Abstract][Full Text] [Related]
12. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
14. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile.
Somoza N; Vargas F; Roura-Mir C; Vives-Pi M; Fernández-Figueras MT; Ariza A; Gomis R; Bragado R; Martí M; Jaraquemada D; Pujol-Borrell R
J Immunol; 1994 Aug; 153(3):1360-77. PubMed ID: 7913115
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune Diabetes: An Overview of Experimental Models and Novel Therapeutics.
You S; Chatenoud L
Methods Mol Biol; 2016; 1371():117-42. PubMed ID: 26530798
[TBL] [Abstract][Full Text] [Related]
16. Original hypothesis: Extracorporeal shockwaves as a homeostatic autoimmune restorative treatment (HART) for Type 1 diabetes mellitus.
Craig K; d'Agostino C; Poratt D; Walker M
Med Hypotheses; 2014 Sep; 83(3):250-3. PubMed ID: 24947195
[TBL] [Abstract][Full Text] [Related]
17. Rehabilitation of adaptive immunity and regeneration of beta cells.
Pasquali L; Fan Y; Trucco M; Ringquist S
Trends Biotechnol; 2006 Nov; 24(11):516-22. PubMed ID: 16963140
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
[TBL] [Abstract][Full Text] [Related]
19. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
20. Role of humoral beta-cell autoimmunity in type 1 diabetes.
Knip M; Siljander H; Ilonen J; Simell O; Veijola R
Pediatr Diabetes; 2016 Jul; 17 Suppl 22():17-24. PubMed ID: 27411432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
